SCHEMBL6540273

SCHEMBL6540273

CC1(C)OCC(Cc2ccc(Sc3cccs3)cc2)N1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.32
ALDH1A1 P00352 4/20 0.32
HSD17B10 Q99714 1/20 0.32
KDM4C Q9H3R0 1/20 0.32
CYP3A4 P08684 4/20 0.32
HPGD P15428 3/20 0.31
MAPT P10636 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PKM P14618 1/20 0.31
DDB1 Q16531 1/20 0.31
CRBN Q96SW2 1/20 0.31
HDAC1 Q13547 1/20 0.31
TBXAS1 P24557 1/20 0.31
CASP3 P42574 1/20 0.31
CASP8 Q14790 1/20 0.31
ABCB1 P08183 1/20 0.30
TSHR P16473 1/20 0.30
HTT P42858 1/20 0.30
LMNA P02545 1/20 0.30
PTPN11 Q06124 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6540261 1.00 ALOX5 (0.32) ALOX5ALDH1A1HSD17B10KDM4CCYP3A4
SCHEMBL6541230 0.86 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL6541226 0.86 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP3A4HPGDMAPT
SCHEMBL6540884 0.81 CCR3 (0.35)
SCHEMBL6540891 0.81 CCR3 (0.35)
SCHEMBL6539667 0.80 PTGIR (0.41) ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL6539664 0.80 PTGIR (0.41) ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL6541597 0.79 KMT2A (0.38) ALDH1A1SMN1; SMN2PKMTSHR
SCHEMBL6541605 0.79 KMT2A (0.38) ALDH1A1SMN1; SMN2PKMTSHR
SCHEMBL6541438 0.77 CAPN1 (0.38) ALDH1A1HSD17B10CYP3A4HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138462-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-07-15 US disclosed
EP-1389185-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-02-18 EP disclosed
WO-2002094770-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138462-A1 Aminoalcohol derivatives BPHL, FANCD2, HRH2 ALOX5 769/4885ALDH1A1 188/4885HSD17B10 1650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.